| Cover Page | Sep. 09, 2024 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Document Period End Date | Sep. 09, 2024 |
| Entity Registrant Name | Aurinia Pharmaceuticals Inc. |
| Entity Incorporation, State or Country Code | A0 |
| Entity File Number | 001-36421 |
| Entity Tax Identification Number | 98-1231763 |
| Entity Address, Address Line One | #140, 14315 -118 Avenue |
| Entity Address, City or Town | Edmonton |
| Entity Address, State or Province | AB |
| Entity Address, Postal Zip Code | T5L 4S6 |
| City Area Code | 250 |
| Local Phone Number | 744-2487 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Shares, without par value |
| Trading Symbol | AUPH |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | false |
| Entity Central Index Key | 0001600620 |
| Amendment Flag | false |
| Current Fiscal Year End Date | --12-31 |
